InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the complete record of transactions filed by Amin Naseem. Officer active across 2 companies, notably Bellerophon Therapeutics, Inc.. Aggregated, 6 disclosures have been logged. History available since 31 December 2021. The latest transaction was disclosed on 12 February 2026 (Disposition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Amin Naseem
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
22,000 shares@ US$21.00100.0% of flowOrdinary SharesSEC:0001104659-26-014438:0
11,000 shares0Ordinary SharesSEC:0001104659-25-072682:0
11,000 shares0Ordinary SharesSEC:0001104659-24-084933:0
47,578 shares0Common StockSEC:0001104659-23-069913:0
84,000 shares0Common StockSEC:0001415889-23-002555:0
39,032 shares0Common StockSEC:0001415889-22-000186:0
6 of 6 declarations
About Amin Naseem
Amin Naseem is a declarant linked to Avadel Pharmaceuticals PLC, where he is a Director, and to Bellerophon Therapeutics, Inc., where he is also a Director. The record shows 6 filings in total, and across the 6 most recent filings held, the period runs from 2022-01-04 to 2026-02-12, with sales of EUR 389018 and no purchases; the most common transaction nature is Attribution.
